ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

ACS Modifies Pap Test Guidelines

November 27, 1987

DC, DCR Boards Angered when NCI Ignored In AIDS Money Amendment

October 26, 1984

NCI Continues Making Improvements In Contract Management

May 22, 1981

M.D. Anderson Opens Centers For Social Workers, Outpatients

November 21, 1986